|Minimum Order Quantity||1 Box|
|Packaging Size||30 Tablets|
|Usage||Personal, Clinical, Hospital|
|Minimum Order Quantity||5 Bottle|
|Dose/Strength (ex. 1 mg or 1 ml)||25|
|Drug Name||Tenofovir Alafenamide|
|Packaging Size||1 x 28|
We are offering Daclahep Tablets to our client. Daclatasvir 60mg (brand names, Natdac, Myekhla, Daclawin ,Dacihep) is a nucleotide analog used in combination with other drugs for the treatment of Hepatitis C virus (HCV) infection. It has been marketed since 2013. Compared to previous treatments, sofosbuvir- daclatasvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy. Sofosbuvir allows most patients to be treated successfully without the use of peginterferon, an injectable drug with severe side effects that is a key component of older drug combinations for the treatment of HCV.